

Bombay Generics Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 35 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.87 M
- Satisfied Charges ₹ 5.23 Cr
- Revenue Growth 1359.34%
- Profit Growth 484.83%
- Ebitda 233.89%
- Net Worth 72.04%
- Total Assets 36.27%
About Bombay Generics
Bombay Generics Private Limited (BGPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 June 1989 and has a history of 35 years and ten months. Its registered office is in Ahmedabad, Gujarat, India.
The Corporate was formerly known as Osho Pharma Pvt Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹0.87 M. The company has closed loans amounting to ₹5.23 Cr, as per Ministry of Corporate Affairs (MCA) records.
Bakulkumar Padia, Krunal Sanghavi, Snehalbhai Shah, and Five other members serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24231GJ1989PTC012305
- Company No.
012305
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jun 1989
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Bombay Generics?
Board Members (8)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Bakulkumar Padia ![]() | Director | 05-Jun-1989 | Current |
Krushnakant Bhalodia ![]() | Director | 01-Feb-2021 | Current |
Dimpal Bhalodiya ![]() | Director | 01-Feb-2021 | Current |
Krunal Sanghavi ![]() | Director | 11-Jul-2016 | Current |
Snehalbhai Shah ![]() | Director | 11-Jul-2016 | Current |
Bharatkumar Patel ![]() | Director | 11-Jul-2016 | Current |
Financial Performance of Bombay Generics.
Bombay Generics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1359.34% increase. The company also saw a substantial improvement in profitability, with a 484.83% increase in profit. The company's net worth Soared by an impressive increase of 72.04%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Bombay Generics?
In 2023, Bombay Generics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Zeon Biotech Private Limited
Ankurkumar Bhalodiya, Krushnakant Bhalodia and 2 more are mutual person
- Phaedrus Life Science Private Limited
Snehalbhai Shah is a mutual person
- Maairee Bio-Remedies Private Limited
Bakulkumar Padia is a mutual person
- Sanghvi Poly Products Private Limited
Krunal Sanghavi is a mutual person
- Reneev Developers Private Limited
Krunal Sanghavi is a mutual person
- Phaedrus Wellness Private Limited
Snehalbhai Shah is a mutual person
Charges (Loans)
₹0.87 M
₹52.25 M
Charges Breakdown by Lending Institutions
- Gujrat State Financial Corporation : 0.09 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
19 Jan 1990 | Gujrat State Financial Corporation | ₹0.87 M | Open |
02 Sep 2023 | Others | ₹4.00 Cr | Satisfied |
12 Sep 2005 | Union Bank Of India | ₹1.15 Cr | Satisfied |
20 Nov 1990 | Union Bank Of India | ₹0.25 M | Satisfied |
20 Nov 1990 | Union Bankl Of India | ₹0.25 M | Satisfied |
How Many Employees Work at Bombay Generics?
Unlock and access historical data on people associated with Bombay Generics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Bombay Generics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bombay Generics's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Bombay Generics
Recent activity within the organization
- Charges
A charge registered on 02 Sep 2023 via Charge ID 100800835 with Others was fully satisfied on 06 Jul 2024.
- Annual General Meeting
Bombay Generics Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
- Charges
A charge with Others amounted to Rs. 40.00 M with Charge ID 100800835 was registered on 02 Sep 2023.
- Balance Sheet
Bombay Generics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Ahmedabad.
- Director Appointment
Ankurkumar Gopalbhai Bhalodiya was appointed as a Director was appointed as a Director on 01 Feb 2021 & has been associated with this company since 4 years 2 months .
- Director Appointment
Krushnakant Bhalodia was appointed as a Director was appointed as a Director on 01 Feb 2021 & has been associated with this company since 4 years 2 months .
Frequently asked questions
What is the Incorporation or founding date of Bombay Generics Private Limited?
Bombay Generics Private Limited was incorporated on 01 Jun 1989.
What is authorized share capital and paid-up capital of Bombay Generics Private Limited?
The authorized share capital of Bombay Generics Private Limited is ₹ 5.00 M and paid-up capital is ₹ 5.00 M.
Who are the current board members & directors of Bombay Generics Private Limited?
Currently 8 directors are associated with Bombay Generics Private Limited.
- Bakulkumar Jayantilal Padia
- Krunal Dilipkumar Sanghavi
- Snehalbhai Jashwantbhai Shah
- Bharatkumar Babulal Patel
- Ankurkumar Gopalbhai Bhalodiya
- Krushnakant Bhalodia
- Dimpal Bhalodiya
- Poojaben Bhalodiya
What is the registered address of Bombay Generics Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Bombay Generics Private Limited is Plot No 2404 Phase-Iv G.I.D.C. Vatva, Ahmedabad, Gujarat, India, 382445.
What is the corporate identification number (CIN) and company number of Bombay Generics Private Limited?
The corporate identification number (CIN) of Bombay Generics Private Limited is U24231GJ1989PTC012305 and the company number is 012305 as per Ministry of Corporate Affairs (MCA).
What is the official website of Bombay Generics Private Limited?
The Official website of Bombay Generics Private Limited is https://www.oshopharma.com
What has been the recent revenue trend for Bombay Generics Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Bombay Generics Private Limited has risen by 1359.34%.
What change has been observed in the net worth of Bombay Generics Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Bombay Generics Private Limited has experienced an upsurge of 72.04%.
What are the total open charges for Bombay Generics Private Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Bombay Generics Private Limited amount to ₹ 0.87 M.
When was the last Balance Sheet of Bombay Generics Private Limited filed with the ROC?
The most recent Balance Sheet for Bombay Generics Private Limited was filed with the ROC on 31 Mar 2023.
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
- Sureshkumar PadiaDirector
DP
Deepakkumar PadiaDirectorVP
Vinaykumar PadiaDirectorST
Sanjay TalatiDirectorBJ
Bhavin JaigovindbhaiDirector
Similar Companies Based on Drug Formulation & Development
- Mylan Laboratories Limited Hyderabad, Telangana, India
- Sun Pharma Laboratories Limited Vadodara, Gujarat, India
- Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
- Lupin Limited Mumbai, Maharashtra, India
- Alkem Laboratories Limited Mumbai, Maharashtra, India
- Hetero Labs Limited Rangareddy, Telangana, India
- Aurobindo Pharma Ltd Hyderabad, Telangana, India
- Cipla Limited Mumbai, Maharashtra, India